These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 41605)

  • 1. The utilization of hypnotics in chronic schizophrenics: some critical remarks.
    Jus K; Jus A; Villeneuve A; Pires P; Fontaine P
    Biol Psychiatry; 1979 Dec; 14(6):955-60. PubMed ID: 41605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B
    Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insomnia therapy and withdrawal of hypnotics].
    Garma L; Widlöcher D; Scherrer J
    Sem Hop; 1982 Nov; 58(42):2441-9. PubMed ID: 6297032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
    Mendels J
    J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eszopiclone (Lunesta), a new hypnotic.
    Med Lett Drugs Ther; 2005 Feb; 47(1203):17-9. PubMed ID: 15767972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When is which hypnotic indicated?].
    Semler P
    Med Klin; 1981 Jan; 76(2):54-5. PubMed ID: 6111743
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Situation and problem of administration methods and the intermission of hypnotics.
    Uchimura N; Takeuchi N; Kuwahara H; Nose I; Hashizume Y; Shirakawa S; Ohyama T; Maeda H
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):295-6. PubMed ID: 12047602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of zopiclone on the sleep of chronic insomniacs.
    Mamelak M; Scima A; Price V
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():156-64. PubMed ID: 7188373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A postmarketing surveillance study of zopiclone in insomnia.
    Mahendran R; Chee KT; Peh LH; Wong KE; Lim L
    Singapore Med J; 1994 Aug; 35(4):390-3. PubMed ID: 7899899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study.
    Pecknold J; Wilson R; le Morvan P
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():57-67. PubMed ID: 2117623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The elderly, sleep habits and use of psychotropic drugs by the French population].
    Ohayon M; Caulet M; Lemoine P
    Encephale; 1996; 22(5):337-50. PubMed ID: 9035990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zopiclone, the third generation hypnotic: a clinical overview.
    Musch B; Maillard F
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():147-58. PubMed ID: 2201726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Hypnotic' prescription patterns in a large managed-care population.
    Roehrs T; Roth T
    Sleep Med; 2004 Sep; 5(5):463-6. PubMed ID: 15341891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Shortcomings in the evaluation and promotion of hypnotic drugs.
    Kales A; Kales JD
    N Engl J Med; 1975 Oct; 293(16):826-7. PubMed ID: 1160976
    [No Abstract]   [Full Text] [Related]  

  • 20. [Novel insomnia drugs, including drugs currently under development].
    Inada K
    Nihon Rinsho; 2009 Aug; 67(8):1590-4. PubMed ID: 19768946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.